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Introduction: Cold intolerance is defined as abnormal pain resulting from exposure to cold stimulation after trauma. 
However, the pathophysiology remains unclear. We recently demonstrated that regional osteoporotic changes 
accompanied with high bone turnover were involved in causing pain-like behaviors in the unloaded hind limbs of 
tail-suspended mice. Bisphosphonate prevented pain-like behaviors and high bone turnover conditions in 
tail-suspended mice. The aims of this study were to examine the relationship between regional osteoporotic changes 
and the induction of hypersensitivity to cold stimulation.  
Materials and Methods: The hind limbs of tail-suspended mice were unloaded for 2 weeks. The von Frey test and 
paw-flick test assessed pain-like behaviors and cold plate test evaluate cold escape behaviors. Furthermore, we 
examined whether cold hypersensitivity associated with regional osteoporotic changes could be improved by 
bisphosphonate, TRPV1 and TRPA1 antagonists. 
Results: Hypersensitivity to cold stimulation was induced more noticeably in the tail-suspended mice, and this effect 
was related to the increased expression of bone metabolism markers. In addition, the cold hypersensitivity was 
improved by the resumption of weight bearing and prevented by bisphosphonate or a TRPV1 antagonist, and was 
accompanied with a decrease in the expression of bone metabolism markers. TRPA1 antagonist significantly improved 
the cold escape behavior but had no significant effects on the expression of those markers. 
Conclusion: We demonstrated that the regional osteoporotic changes accompanying a high bone turnover state could 
be involved in the induction of hypersensitivity to cold stimulation in the tail-suspended mice.  
 





Abnormal pain after exposure to cold is one of the most common long-term complaints of patients after trauma 
and nerve injury. Cold intolerance is defined as abnormal pain, numbness, weakness or stiffness of the hand and 
fingers after exposure to mild-to-severe cold. The incidence of cold intolerance in humans with a nerve injury is 
estimated to range from 56% to 83%. Unfortunately, the only remedy prescribed for cold intolerance is simply to 
instruct the patient group to avoid cold stimulation as the pathophysiology of cold intolerance remains unclear [1–6]. 
A previous study showed that bad weather and cold conditions were associated with the aggravation of pain in the 
Japanese population [7]. However, for patients with chronic pain who live in a cold climate, cold intolerance is a real 
problem and leads to a deterioration in activities of daily living. 
Several studies demonstrated that pathological conditions with refractory skeletal pain were often characterized by 
regional osteoporotic changes, such as transient osteoporosis of the hip, regional migratory osteoporosis or complex 
regional pain syndrome (CRPS) [8-11]. We also reported CRPS cases with severe foot or ankle pain who showed 
marked regional osteoporotic changes. Interestingly, both the severe pain and regional osteoporotic changes in such 
cases were markedly improved by treatment with bisphosphonate as an anti-osteoporotic drug [12]. In addition, we 
recently demonstrated that regional osteoporotic changes in the unloaded hind limbs of tail-suspended mice were 
related to the induction of pain-like behaviors [13]. Another recent study demonstrated that reduced bone mineral 
density (BMD) was associated with hypersensitivity to cold stimulation in ovariectomized (OVX) mice as an animal 
model of postmenopausal osteoporosis [14]. These studies encouraged us to examine whether pathological conditions 
with associated regional osteoporotic changes, which are characterized by chronic skeletal disease with refractory 
limb pain, are related to the induction of cold intolerance, and whether improvement in the regional osteoporotic 
changes could affect cold intolerance status. The aims of the present study were to examine the relationship between 
regional osteoporotic changes and the induction of hypersensitivity to cold stimulation using tail-suspended mice, 
which present regional osteoporotic changes in the unloaded hind limbs [13]. 
 
2. Materials and methods 
2.1. Animals 
The present experiments were approved by the University Animal Care Committee (approval number: 16-066) and 
were performed in accordance with the ethical guidelines of the National Institute of Health. Every effort was made to 
minimize animal suffering and the number of animals used. Experiments were conducted on 8-week-old male 
C57Bl/6J mice weighing 20–25 g (Japan SLC, Hamamatsu, Japan). The mice were housed in a temperature-controlled 
room (21 ± 1˚C) with a 12 h light/dark cycle and given free access to food and water. The animals were humanely 
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sacrificed with an intraperitoneal injection of pentobarbital sodium (0.5 mg/kg) after completion of the experiments. 
We used a total of 124 mice, consisting of 80 tail-suspended and 44 control mice. Our previous study demonstrated 
that there are no significant differences in the pain-like behaviors or bone turnover between 2 kinds of control, one in 
which the mice were tail-suspended but the hind limbs were free to be loaded, and the other in which the mice were 
freely housed without any tail suspension [13]. In this study, we therefore used mice without any tail suspension as 
controls. The bilateral femurs and tibias were removed at 2 weeks after the start of tail suspension for evaluation of 
bone micro-architecture by micro-computed tomography (μCT) and the expression of osteoblast and osteoclast 
regulators.  
 
2.2 Tail-suspension model 
Hind limb unloading was accomplished as described in our previous report [13]. We used minimal restraints to 
avoid the risk of stress during the hind limb unloading procedure. Briefly, the tail was suspended to maintain the mice 
at a head-down tilt of 30˚ with the hind limbs elevated above the floor of the cage for 2 weeks. The mice were allowed 
a 360˚ range of movement to facilitate free movement about the cage. To monitor the effects of tail suspension on 
general body condition, we measured the body weight and conducted a social interaction test on the mice during the 
experimental period as described in our previous study [13]. We confirmed that the stress on the mice in our 
experiments could be regarded as minimal based on the fact that there were no significant changes in body weight or 
on the social interaction test [13, 15] between the tail-suspension and control groups (data not shown), with the same 
results observed in our previous study [13]. 
 
2.3. Assessment of pain-like behavior 
Behavioral tests were performed as previously described [13, 16, 17] prior to tail suspension and every week after 
the start of tail suspension and resumption of weight bearing. In brief, to assess the mechanical withdrawal response 
(von Frey test), the mice were placed in plastic chambers above a wire mesh floor, which allowed full access to the 
hind paw. A 1.34 g von Frey filament (Semmes-Weinstein Monofilaments, North Coast Medical Inc., San Jose, CA, 
USA) was used to produce mechanical tactile stimuli, which were applied to the middle area of the plantar surface of 
the hind paws. Each hind paw was probed consecutively with 10 stimulations, while alternating between the hind 
paws for each set. This was repeated at least 5 times at intervals of at least 10 min and the final value was obtained by 
averaging the 5 measurements. Mechanical sensitivity was evaluated as the rate of withdrawal responses. Visible 
lifting of the stimulated hind limb was considered to be a withdrawal response [13, 18]. Thermal nociceptive testing 
(paw-flick test) was conducted using an analgesimeter (Plantar test 7370, Ugo Basile, Italy). The mice were placed in 
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plastic chambers (6×4×4 cm) and left unrestrained. Radiant heat was applied to the plantar surface of the hind paws 
until it was actively withdrawn by the animal. The thermal withdrawal response was measured as the latency of hind 
limb paw withdrawal. Paw withdrawal latency (PWL) was considered to be an index of the thermal nociceptive 
threshold, and a decrease in this measurement indicated thermal hyperalgesia. Light beam intensity was adjusted so 
that the basal PWL was 7–10 s. The cut-off time was set at 15 s to avoid tissue damage [13, 16, 17]. The observer was 
blinded to the treatment regimen received by each mouse. 
 
2.4. Assessment of cold sensitivity 
We assessed the effect of tail suspension on cold hypersensitivity by cold plate test. Cold sensitivity was assessed 
with the No. 35150 Hot/Cold Plate apparatus (Ugo Basile, Italy). In the cold plate test, the mice were individually 
placed in the center of a cold plate maintained at 5˚C in a transparent Plexiglas cylinder [19–22]. The number of 
escape behaviors, such as lifting a hind limb paw or walking backwards and jumping, was recorded during a period of 
60s [20]. The test was performed 3 times with a >15 min interval between each assessment to avoid cutaneous 
sensitization. The average of the 3 measurements for each animal was used as its individual data [14, 23]. The 
observer was blinded to the treatment regimen received by each mouse. 
 
2.5. Evaluation of the expression of osteoblast and osteoclast regulators in the femur, and TRPV1, TRPA1, and 
TRPM8 in the spinal cord, dorsal root ganglia and glabrous skin of the hind paw  
Mice were anesthetized by an intraperitoneal injection of pentobarbital; and the bilateral femurs, the spinal cord 
and dorsal root ganglia at L4 and L5, and the bilateral glabrous skin of the plantar surface of the hind paws were 
excised. The samples from tail-suspended mice treated with or without reagents, and from non-tail-suspended mice as 
the control were individually homogenized in 1 ml TRIZOL reagent (Invitrogen, Carlsbad, CA, USA) 10 times at 
3000 rpm/30 s using a bead crusher (TITEC, Tokyo, Japan). The homogenates were centrifuged at 15000 ×g for 15 
min at 4˚C and the supernatants were then extracted. Total RNA was individually isolated from the whole femurs from 
each mouse, and then reverse transcribed (RT) into cDNA by polymerase chain reaction (PCR) using an RNA PCR kit 
(Quiagen, Takara BIO Inc., Tokyo, Japan) according to the manufacturer's protocol. In this study, we measured the 
expression of transient receptor potential channel vanilloid subfamily member 1 (TRPV1), which is a main class of 
acid-sensing nociceptors; transient receptor potential cation channel subfamily A member 1 (TRPA1), which is a 
non-selective cation channel for nociceptors and contributes to cold hypersensitivity [24]; and transient receptor 
potential channel melastatin subfamily member 8 (TRPM8), which contributes to sensing unpleasant cold stimuli and 
mediating the effects of cold analgesia [25]. The primers were used as a previously described (Table1) [17, 26–29]. 
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Reactions were carried out by PCR as follows; 30 cycles at 95 °C for 40s, 55 °C for 40 s and 72 °C for 40 s for 
TRPV1and GAPDH; 35 cycles at 94°C for 30 s, 65°C for 30 s and 72°C for 60 s for RANKL; 30 cycles at 95°C for 
30 s, 64 °C for 30 s and 72 °C for 30 s for Runx2, Osterix and osteocalcin; 30 cycles at 94 °C for 30s, 58 °C for 30 s 
and 72 °C for 60 s for TRPA1; and 40 cycles at 94 °C for 30s, 60 °C for 30 s and 72 °C for 60 s for TRPM8. Reaction 
products were analyzed by electrophoresis using 10ml of each reaction mixture on 1.5% agarose gels, and visualized 
by ethidium bromide (Sigma Chemical Co.) staining. A 100 bp DNA ladder served as a size marker. A 
computer-assisted image analyzer (Luminous Imager, AISIN, Japan) was used to semi-quantitatively measure the 
values of the target gene bands, which were expressed as the ratio relative to that of GAPDH in the same sample. 
Values in the graphs are the means ± SD obtained from 4 independent experiments. The values of the target gene 
bands were normalized to the level of GAPDH gene expression in the same sample for semi-quantitative 
measurement.  
 
2.6. Administration of drugs and chemicals 
Alendronate (0.02 mg/kg of body weight diluted in physiological saline) (ALN; Merck & Co. Inc., NJ, USA), a 
potent anti-resorptive agent, was administered to the mice subcutaneously [16] once a day for 2 weeks during tail 
suspension [13]. The TRPV1 antagonist N-(3-methoxyphenyl)-4-chlorocinnamide (SB366791; BIOMOL 
International; Plymouth Meeting, PA, USA) were used as previously described [1, 12]. In brief, SB366791 in 100% 
dimethyl sulfoxide (DMSO) at a concentration of 1 mg/100 μl was intraperitoneally administered at a dose of 1.0 
mg/kg diluted in physiological saline, with DMSO at a dose of 50 μl/kg in physiological saline as the vehicle. Mice 
were given a single injection after tail-suspension for 2 weeks. To evaluate the effects of continuous treatment with the 
TRPV1 antagonist with regard to the prevention of regional bone loss, SB366791 was intraperitoneally administered 
at a dose of 1.0 mg/kg once a day for 2 weeks during tail-suspension.  
The TRPA1 antagonist HC-030031 (Enzo Life Sciences, Exeter, UK) was used as previously described [20]. In 
brief, HC-030031 was prepared in 0.5% methylcellulose (Wako) [20, 24, 30]. HC-030031 was intraperitoneally 
administered at a dose of 100 mg/kg diluted in physiological saline or vehicle (0.5% methyl cellulose) 30 minutes 
prior to the cold plate test. Mice were given a single injection after tail-suspension for 2 weeks. The cold plate test was 
performed at 0 (post- tail suspension) and 0.5h after the administration of these antagonists.  
The reagents were prepared by one of the authors and injected into the mice by a second author who was blinded to 
their preparation. In addition, the investigator recording data for the behavioral studies was blinded to the type of 




2.7. Evaluation of bone micro-architecture by micro-computed tomography (μCT) 
The isolated proximal tibia was scanned on a micro-computed tomography (μCT) system (ScanXmate-L090, 
Comscantecno, Yokohama, Japan) operated at a lamp voltage of 75 kV and a current of 100 μA using X sys FP 
Version 1.7 and coneCTexpressIV 1.32 (Comscantecno) software. Samples were scanned at a magnification factor of 
10.9 and a spatial resolution of 9.171 μm/pixel. Captured images were rendered using TRI/3D BON (Ratoc System 
Engineering Co., Ltd., Tokyo, Japan) software. Evaluation of osteoporotic changes was performed on the basis of the 
bone surface to bone volume ratio (BS/BV, 1/mm), trabecular thickness (Tb.Th, μm), bone volume fraction 
(BV/TV, %), trabecullar number (Tb.N) and trabecullar separation (Tb.Sp).  
 
2.8. Statistical Analysis 
All data are presented as means ± standard deviation (SD). To determine differences between groups, 
measurements were repeated at least three times for each sample, and the individual mean value was used for the 
statistical analysis. The statistical significance between 2 groups was determined using a Student's t-test, and that 
among 3 groups was determined using ANOVA followed by Tukey's post-hoc test. Differences with p values of <0.05 
were considered to be statistically significant.  
 
3. Results 
3.1. Pain-like and cold escape behaviors in tail-suspended mice 
During the 6 weeks experiment including 2-week tail suspension and 4-week resumption of weight bearing, the 
pain-like behaviors on the von Frey tests at 2 (p < 0.001), 3 (p < 0.001) and 4 (p < 0.001) weeks, and on the paw-flick 
test at 2 (p < 0.001), 3 (p < 0.01) and 4 (p < 0.01) weeks in the tail-suspended mice were significantly greater in 
comparison to those in the control mice (Figs. 1a and b). These results corresponded with those of our previous study 
[13]．  
Escape behaviors in response to cold stimulation were assessed by cold plate test. The cold escape behaviors on 
the cold plate test at 2 (p < 0.01) and 3 (p < 0.05) weeks in the tail-suspended mice were significantly increased in 
comparison with those of the control mice (Fig. 1c). 
The induction of pain-like behaviors on the von Frey test and paw-flick test in tail-suspended mice were 
significantly prevented by treatment with ALN at 2 (a, p < 0.001; b, p < 0.01), 3 (p < 0.001) and 4 (p < 0.001) weeks 
during the 2-week tail suspension and 4-week resumption of weight bearing, with the observed values comparable to 
those in the control mice (Figs. 1a and b). The cold escape behaviors on the cold plate test were also significantly 
prevented by ALN treatment at 2 (p < 0.001) and 3(p < 0.001) weeks during the 2-week tail suspension and 4-week 
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resumption of weight bearing, the observed values for which were also comparable to those in the control mice (Fig. 
1c).  
 
3.2. Changes in the expression of osteoblast and osteoclast differentiation regulators in tail-suspended mice 
We examined the effects of bisphosphonate (ALN) on the expression of osteoblast and osteoclast regulators at 2 
weeks after the start of treatment during tail-suspension. The expression levels of osterix, oseteocalcin and RANKL 
were significantly increased in the tail-suspended mice (vehicle) compared to those in the mice without any tail 
suspension (control).  ALN significantly prevented the increase in the expression levels of osterix, osteocalcin and 
RANKL in the tail-suspended mouse (ALN) (Figs. 1d and e). There were no significant changes in Runx2 expression 
with or without ALN treatment in the tail-suspended mice in comparison with that in the control mice. 
 
3.3. Effects of bisphosphonate (ALN) on regional osteoporotic changes in tail-suspended mice 
ALN administration for 2 weeks during tail-suspension prevented the increase in BS/BV and Tb.Sp, and the 
decrease in BV/TV, Tb.Th and Tb.N in the proximal tibia bone to levels comparable to those in the control mice at 2 
weeks after the start of tail-suspension, although there were no significant changes in Tb.N or Tb.Sp (Fig. 2). 
 
3.4. Effects of TRPV1 and TRPA1 antagonists on cold escape behaviors after tail suspension 
The increased cold escape behaviors observed after 2-week tail-suspension were significantly improved by 
treatment with TRPV1 and TRPA1 antagonists to levels comparable to those in the controls (Figs. 3a and b) at 2 
weeks after the start of tail-suspension. 
 
3.5. Effects of TRPV1 and TRPA1 antagonists on the expression of osteoblast and osteoclast differentiation 
regulators in tail-suspended mice 
The increased expression levels of osterix, osteocalcin and RANKL in the tail-suspended mice were significantly 
inhibited by treatment with the TRPV1 antagonist (Figs. 4a and b) at 2 weeks after the start of tail-suspension. On the 
other hand, the TRPA1 antagonist had no significant effect on the expressions of those regulators (Figs. 4c and d). 
 
3.6. Preventive effects of continuous treatment with the TRPV1 antagonist during tail-suspension on cold escape 
behaviors, and the expression of osteoblast and osteoclast differentiation regulators 
Continuous treatment with the TRPV1 antagonist for 2 weeks during tail-suspension significantly prevented the 
induction of cold escape behaviors (Fig. 5a). The treatment also significantly prevented increases in the expression 
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levels of osteoblast and osteoclast differentiation regulators such as osterix, osteocalcin and RANKL in the 
tail-suspended mice (Figs. 5b and c).  
 
3.7. Expression of TRPV1, TRPA1, and TRPM8 in the spinal cord and glabrous skin of the hind paw 
An array of receptors (TRPV1, TRPA1 and TRPM8) were expressed in the spinal cord and dorsal root ganglia (Fig. 
6a) and the glabrous skin of the hind paw (Fig. 6c) in the mice, although there were no significant differences in the 
expression levels between the mice with and without tail-suspension (Figs. 6b and d).  
 
4. Discussion 
Approximately 50 % of individuals with chronic pain complain that their pain worsens in cold weather [7]. Cold 
intolerance, which is defined as abnormal pain, numbness, weakness or stiffness of the hand and fingers after exposure 
to mild-to-severe cold, is a severe problem and has a significant impact on quality of life in the patients with chronic 
skeletal pain. Most of the previous studies focused on the pathogenesis of cold intolerance after nerve injuries and 
trauma, however, this remains unclear [1–7]. In this study, we demonstrated that regional osteoporotic changes were 
associated with the induction of hypersensitivity to cold stimulation based on cold escape behaviors using 
tail-suspended mice. In addition, the induction of cold escape behaviors in the mice was related to the increased 
expression of osteoblast and osteoclast differentiation markers, and improvement and prevention of the behaviors 
were correlated with a decrease in expression of those markers by resumption of weight bearing or treatment with 
ALN. These results indicated that a high bone turnover state of osteoporotic bone could be involved in the induction 
of cold escape behavior in the tail-suspended mice in the same manner as mechanical and thermal withdrawal 
responses [12, 13]. Regarding the mechanisms underlying hypersensitivity to cold stimulation, such as cold 
intolerance in the patients with skeletal chronic pain, injured peripheral nerves [2, 4], vascular dysfunction [31, 32], 
disturbance in rewarming patterns [30], and thermoregulation [6] and pathological conditions after fracture [33] were 
all suggested as the contributing factors. On the other hand, radiological findings in patients with skeletal chronic pain 
were characterized by the development of regional bone loss in the affected limb [8–12]. Recently, we demonstrated 
that regional osteoporotic changes accompanied by high bone turnover in the unloaded hind limbs of tail-suspended 
mice was involved in the induction of pain-like behaviors [13]. A pathophysiological acidic microenvironment was 
created by activated osteoclasts under a high bone turnover state. The acidic environment of the bone could activate 
acid-sensing nociceptors, including transient receptor potential channel vanilloid subfamily member 1 (TRPV1) and 
acid-sensing ion channels (ASICs) [16, 17]. In addition, increases in the ATP levels in the bone by osteoclast 
activation stimulated P2X2/3, another nociceptor [17, 27]. These conditions due to osteoporotic changes could be one 
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of the factors underlying the induction of pain-like behaviors [16, 17, 27]. Thus, we believe that the 
pathophysiological conditions associated with regional osteoporotic changes with a high bone turnover state could be 
involved in the induction of hypersensitivity to cold stimulation.  
The transient receptor potential ankyrin 1 (TRPA1) is a nonselective cation channel implicated in noxious cold, 
although its role in cold-sensing remains controversial [34, 35]. In this study, we showed that the antagonist to TRPA1 
significantly improved cold escape behaviors and had no significant effects on the expression of osteoblast and 
osteoclast differentiation regulators. On the other hand, TRPV1 significantly improved behaviors and, additionally, 
inhibited the increases in the expressions of those regulators. TRPV1 is a member of a family of polymodal and 
nonselective cation channels that are predominantly expressed by the sensory nerve fibers of somatic and autonomic 
afferent neurons [36]. Recently, using mouse models, we and another study have demonstrated that TRPV1 directly 
regulates osteoblast and osteoclast differentiation and function, and TRPV1 blockade protects against osteoporotic 
changes [26, 27, 37]. However, TRPV1 has no functional role in cold sensation. We, therefore, speculated that a 
TRPA1 antagonist directly improved the cold escape behaviors due to inhibition of its receptor activation, and a 
TRPV1 antagonist indirectly improved it through regulation of osteoblast and osteoclast differentiation and function, 
which is involved in the induction of cold escape behaviors.  
Several studies indicated that increases in the number of cold sensing receptors, such as TRPA1 and transient 
receptor potential melastatin 8 (TRPM8), contributes to cold hyperalgesia after inflammation and nerve injury [38, 39]. 
Those receptors were shown to be highly expressed in the dorsal root ganglia, spinal cord and skin [25, 40]. In the 
current study, we did not find any significant differences in the expression levels of TRPV1, TRPA1 and TRPM8 in 
the spinal cord and root ganglia, or glabrous skin of the hind paw between the mice with and without tail-suspension. 
These results indicate that the expression of cold-sensing receptors was not affected by the high bone turnover state 
under tail-suspension.  
We demonstrated that the treatment with bisphosphonate during tail-suspension, which improved bone turnover 
and osteoporotic changes as an anti-resorptive agent, prevented both the induction of cold escape behaviors and the 
increase in osteoblast and osteoclast differentiation marker expression. Regarding the treatment of patients with 
chronic skeletal pain, we think that bisphosphonate might act to prevent the induction or aggravation of 
hypersensitivity to cold stimulation associated with regional osteoporotic changes. With regard to clinical practice, we 
believe that bisphosphonate is a candidate agent for the treatment of cold hypersensitivity in the patients with chronic 
skeletal pain.  
The present study has several limitations. First, the tests for pain-like and cold escape behaviors including the von 
Frey test, paw-flick and cold plate test have not yet been established as surrogate methods for measuring skeletal pain 
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and cold hypersensitivity although those tests were used in a number of previous studies [18–22, 41–43]. Second, we 
did not separately measure the spinal cord and dorsal root ganglia for the expression of TRPV1, TRPA1 and TRPM8. 
Third, we could not demonstrate the expression of TRPV1, TRPA1 and TRPM8 at a protein or activation level. Fourth, 
the previous studies indicated that the expressions of TRPV1, TRPA1 and TRPM8 changed in the dorsal root ganglia 
and spinal cord using nerve injury model and other skeletal pain models [38, 39], of which results were different from 
those in our study. Fifth, we did not examine the roles of osteocytes in relation to cold escape behaviors in the 
tail-suspended mice although these cells are thought to be involved in the genesis of the osteoporotic changes 
associated with unloading. Thus, we think that it would be worthwhile to continue this research in order to elucidate 
the mechanisms by which bone turnover state influences cold hypersensitivity in future. 
In conclusion, we demonstrated that regional osteoporotic changes accompanied with a high bone turnover state 
were associated with the induction of hypersensitivity to cold stimulation as observed by cold escape behavior using 
tail-suspended mice. In addition, inhibition of a high bone turnover state by resumption of weight bearing and 
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Figure 1 The changes of pain-like and cold escape behaviors associated with the expression changes of osteoblast and 
osteoclast differentiation regulators in tail-suspended mice 
Tail-suspended mice (black square) showed a significant increase in pain-like behaviors on the von Frey test (a), 
paw-flick test (b) and cold escape behaviors (c). The resumption of weight bearing after tail suspension recovered the 
pain-like and cold escape behaviors (black square) to the same levels as those in the control mice (white circle, n = 8). 
Treatment with ALN (ALN, white triangle, n = 8) for 2 weeks during tail-suspension significantly prevented the 
induction of pain-like and cold escape behaviors, compared with those in the tail-suspended mice without treatment 
(vehicle, black square, n = 8), which were comparable to those in the control mice (control, white circle, n = 8).  
Treatment with ALN (ALN, gray bar, n = 4) for 2 weeks significantly prevented increases in the expression levels of 
osterix, osteocalcin and RANKL (vehicle, black bar, n = 4) during tail-suspension to the same levels as those in the 
control mice (control, white bar, n = 4) (d, e). There were no significant changes in Runx2 expression with or without 
ALN treatment in tail-suspended mice in comparison with that in the control mice (d, e).  





P < 0.01, 
†††
P < 0.001 (vehicle treatment in tail-suspended mice versus control mice) (a-c, e). 
Duration (weeks), weeks after the beginning of tail suspension; ALN (arrow), 2-week treatment with alendronate 
during tail suspension. 
 
Figure 2 Regional osteoporotic changes in tail-suspended mice prevented by treatment with bisphosphonate (ALN) 
The treatment with ALN for 2 weeks (ALN, gray bar, n = 4) prevented the regional osteoporotic changes (a). The 
BV/TV (b), BS/BV (c) and Tb.Th (d) in tail-suspended mice (vehicle, black bar, n = 4) were significantly prevented 
by ALN treatment to the same levels as those in the control mice (control, white bar, n = 4). ALN treatment also 
prevented changes in Tb.N (e) and Tb.Sp (f), although the differences were not significant. Tukey's post-hoc test, *p 
< 0.05 
 
Figure 3 Effects of a TRPV1 and TRPA1antagonists on cold escape behaviors in tail-suspended mice 
The cold escape behaviors were significantly increased in the hind limb of tail-suspended mice (vehicle, black bar, n 
= 8) in comparison with those in the mice without any tail suspension (control, white bar, n = 8). Treatment with a 
TRPV1 antagonist (a, +anti TRPV1) and a TRPA1 antagonist (b, +anti TRPA1) significantly improved the cold escape 




TRPV1 and TRPA1 antagonists were administered at 0.5 hours (h) before testing. Tukey's post-hoc test, *p < 0.05, 
***p < 0.001  
 
Figure 4 Effects of TRPV1 and TRPA1 antagonists on the expressions of Runx2, osterix, osteocalcin and RANKL in 
the bone tissue of tail-suspended mice 
The increased expression levels of osterix, osteocalcin and RANKL in tail-suspended mice (vehicle, black bar, n = 4) 
were significantly inhibited by treatment with TRPV1 (a, b) to levels comparable to those in control mice without any 
tail suspension (control, white bar, n = 4). Runx2 expression was also inhibited by the treatment, although the 
difference was not significant. On the other hand, the TRPA1 antagonist had no effect on the increase in the expression 
levels of those regulators in tail-suspended mice (c, d). Tukey's post-hoc test, *p < 0.05, **p < 0.01  
 
Figure 5 Preventative effects of continuous treatment with a TRPV1 antagonist during tail-suspension on cold escape 
behaviors and the expression of osteoblast and osteoclast differentiation regulators 
Continuous treatment with a TRPV1 antagonist (+anti TRPV1, gray bar, n = 8) for 2 weeks during tail-suspension 
significantly prevented the increase of cold escape behaviors in tail-suspended mice (vehicle, black bar, n = 8) to 
comparable levels as those in control mice without any tail suspension (control, white bar, n = 8) (a), associated with 
significant prevention (+ anti-TRPV1, gray bar, n = 4) of the increased expression of osterix, osteocalcin and RANKL 
in tail-suspended mice (vehicle, black bar, n = 4) (b, c). Mice without any tail suspension (control, white bar, n = 4). 
Tukey's post-hoc test, 
*
p < 0.05, 
**
p < 0.01 
 
Figure 6 Expression of TRPV1, TRPA1 and TRPM8 in the spinal cord and the glabrous skin of hind paw 
An array of receptors (TRPV1; TRPA1; TRPM8) was expressed in the spinal cord and dorsal root ganglia (a) and 
the glabrous skin of hind paw (c). The expression levels of these receptors did not differ significantly between mice 








Table 1 Primer sequences 
Gene name Forward primer Reverse primer 
Runx2 GCTTGATGACTCTAAACCTA  AAAAAGGGCCCAGTTCTGAA 
Osterix AGGCACAAAGAAGCCATAC  AATGAGTGAGGGAAGGGT 
Osteocalcin CTCACTCTGCTGGCCCTG  CCGTAGATGCGTTTGTAGGC 
RANKL GGTCGGGCAATTCTGAATT GGGAATTACAAAGTGCACCAG 
TRPV1 AAGGCTTGCCCCCCTATAA  CACCAGCATGAACAGTGACTGC 
TRPA1 CAATGCTCTGGAATGGGTTA CCAAAGGTCAGGACTGGGTA 
TRPM8 GGCTGGAGATGAGATTGTGAG GCTGAAGTGGGTGGAGAAGA 
GAPDH  ACCACAGTCCATGCCATCAC TCCACCACCCTGTTGCTGTA 
 
